Nutriband Inc., a Nevada corporation, was founded on January 4, 2016. They are primarily engaged in the development of a transdermal drug portfolio. Their primary product is their Abuse Deterrence Fentanyl Transdermal System, and they are developing a slow-release fentanyl transdermal product for clinicians and patients for the treatment of chronic pain requiring round-the-clock opioid therapy, combined with properties designed to help combat the opioid crisis by discouraging abuse and misuse of fentanyl patches. 

NTRB

NTRB Profile